Araştırma Makalesi
BibTex RIS Kaynak Göster

DEVELOPMENT AND IN VITRO CHARACTERIZATION OF NANOEMULSION AND NANOEMULSION BASED GEL CONTAINING ARTEMISIA DRACUNCULUS ETHANOL EXTRACT

Yıl 2022, Cilt: 2 Sayı: 2, 36 - 43, 06.04.2022

Öz

Aim: Tarragon, or Artemisia dracunculus, is a member of the Asteraceae family that grows wild in Eastern Anatolia of Turkey. According to previously published studies, Artemisia dracunculus extracts possess antibacterial, antifungal, antioxidant and anti-inflammatory effects. Thus, these extracts can be used to heal wounds. Nanoemulsion (NE) is a suitable dosage form for the application of active substances/compounds via the skin. The aim of this study is to develop and in vitro characterize NE and NE-based gel formulations containing Artemisia dracunculus ethanol extract.
Methods: Extract-containing (E-NE) or blank (B-NE) NE formulations were prepared using ethyl oleate, Lipoid S100, Tween 80, Pluronic F127, DMSO, and ultrapure water. NaCMC was added to NE formulations to obtain NE-based gels (NEGs). The droplet size, PDI and zeta potential values of NEs were determined; pH measurement, FT-IR and rheological analyzes were also performed for NEs and NEGs.
Results: The droplet size and zeta potential values of B-NE and E-NE were found as 139.13±5.15 nm and 135.59±4.81 nm, (-)27.53±2.05 mV and (-)26.28±3.21 mV, respectively. Also, PDI values of NE formulations were <0.3, indicating monodispersity. The pH values of NEs and NEGs were found in the range of 4.26±0.10 - 6.16±0.03, using suitably for topical application. In addition, NEGs formulations showed a pseudoplastic behavior which is important for the topical application. FT-IR results showed that the extract is completely dissolved in the oil phase of formulations.
Conclusion: The NE and NEG may be useful for the topical application of Artemisia dracunculus ethanol extract.

Teşekkür

Yasar Furkan KILINBOZ would like to thank to the scholarship along his postgraduate program provided by the Turkish Scientific and Technical Research Council (TUBITAK).

Kaynakça

  • 1. Benli M, Kaya I, Yiğit N. Screening antimicrobial activity of various extracts of Artemisia dracunculus. L. Cell Biochem Funct, 2007;25(6):681-686.
  • 2. Obolsky D, Pischel B, Feistel N, Glotov N, Heinrich M. Artemisia dracunculus L. (Tarragon): A critical review of its traditional use, chemical compositions, pharmacology, and safety. J. Agric. Food. Chem., 2011;59(21):11367-11385.
  • 3. Ranjbar R, Yousefi A. Artemisia dracunculus in combination with chitosan nanoparticle biofilm improves wound healing in MRSA infected excisional wounds: an animal model study. EurAsia J Biosci. 2018;12:219-226.
  • 4. Minda D, Ghiulai R, Banciu CD, Pavel IZ, Danciu C, Racoviceanu R et al. Phytochemical profile, antioxidant and wound healing potential of three Artemisia species: in vitro and in ovo evaluation. Appl. Sci, 2022;12:1359.
  • 5. Ugur Kaplan AB, Cetin M, Orgul D, Taghizadehghalehjoughi A, Hacimuftuoglu A, Hekimoglu S. Formulation and in vitro characterization of topical nanoemulsion and nanoemulsion-based gels containing daidzein. J Drug Deliv Sci Technol. 2019;52:189-203. 6. Lovelyn C. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011;2:24-32.
  • 7. Tadros T, Izquierdo P, Esqueana J, Solans C. Formation and stability of nanoemulsions, Adv. Colloid Interface Sci. 2004;108-109:303-318.
  • 8. Chakrabarti S, Chattopadhyay P, Islam J, Ray S, Raju PS, Mazumder B. Aspects of nanomaterials in wound healing. Current Drug Delivery. 2019;16:26-41.
  • 9. Ahmad N, Ahmad R, Al-Quadihi A, Alaseel SE, Fita İZ, Khalid MS et al. Preparation of a novel curcumin nanoemulsion by ultrasonication and its comparative effects in wound healing and the treatment of inflammation. RSC Adv. 2019;9:20192.
  • 10. Kazemi M, Mohammadifar M, Aghadavoud E, Vakili Z, Aarabi MH, Talaei SA. Deep skin wound healing potential of lavender essential oil and licorice extract in a nanoemulsion form: Biochemical, histopathological and gene expression evidence. Journal of Tissue Viability. 2020;29:116-124.
  • 11. Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical drug delivery of lipophilic drugs, Int. J. Pharm. 2017; 526:353-365.
  • 12. Choudhury H, Gorain B, Pandey M, Chatterjee LA, Sengupta P, Das A et al.Recent Update on Nanoemulgel as Topical Drug Delivery System. J Pharm Sci. 2017;106(7):1736-1751.
  • 13. Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. Int J Pharm. 2017; 30;526(1-2):353-365.
  • 14. Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems- a review (Part 2). Trop. J. Pharmaceut. Res. 2013;12:265-273.
  • 15. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarriers systems. Pharmaceutics. 2018;10:57.
  • 16. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is below 5, which is beneficial for its resident flora. International Journal of Cosmetic Science. 2006; 28(5):359-370.
  • 17. El-Leithy ES, Makky AM, Khattab AM, Hussein DG. Nanoemulsion gel of nutraceutical co-enzyme Q10 as an alternative to conventional topical delivery system to enhance skin permeability and anti-wrinkle efficiency. International Journal of Pharmacy and Pharmaceutical Sciences. 2017; 9(10):207-217.
  • 18. Kandilli B, Ugur Kaplan AB, Cetin M, Taspinar N, Ertugrul MS, Aydin IC et al. Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method: in vitro and in vivo studies. Drug Development and Industrial Pharmacy. 2020;46(7):1063-1072.
Yıl 2022, Cilt: 2 Sayı: 2, 36 - 43, 06.04.2022

Öz

Kaynakça

  • 1. Benli M, Kaya I, Yiğit N. Screening antimicrobial activity of various extracts of Artemisia dracunculus. L. Cell Biochem Funct, 2007;25(6):681-686.
  • 2. Obolsky D, Pischel B, Feistel N, Glotov N, Heinrich M. Artemisia dracunculus L. (Tarragon): A critical review of its traditional use, chemical compositions, pharmacology, and safety. J. Agric. Food. Chem., 2011;59(21):11367-11385.
  • 3. Ranjbar R, Yousefi A. Artemisia dracunculus in combination with chitosan nanoparticle biofilm improves wound healing in MRSA infected excisional wounds: an animal model study. EurAsia J Biosci. 2018;12:219-226.
  • 4. Minda D, Ghiulai R, Banciu CD, Pavel IZ, Danciu C, Racoviceanu R et al. Phytochemical profile, antioxidant and wound healing potential of three Artemisia species: in vitro and in ovo evaluation. Appl. Sci, 2022;12:1359.
  • 5. Ugur Kaplan AB, Cetin M, Orgul D, Taghizadehghalehjoughi A, Hacimuftuoglu A, Hekimoglu S. Formulation and in vitro characterization of topical nanoemulsion and nanoemulsion-based gels containing daidzein. J Drug Deliv Sci Technol. 2019;52:189-203. 6. Lovelyn C. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011;2:24-32.
  • 7. Tadros T, Izquierdo P, Esqueana J, Solans C. Formation and stability of nanoemulsions, Adv. Colloid Interface Sci. 2004;108-109:303-318.
  • 8. Chakrabarti S, Chattopadhyay P, Islam J, Ray S, Raju PS, Mazumder B. Aspects of nanomaterials in wound healing. Current Drug Delivery. 2019;16:26-41.
  • 9. Ahmad N, Ahmad R, Al-Quadihi A, Alaseel SE, Fita İZ, Khalid MS et al. Preparation of a novel curcumin nanoemulsion by ultrasonication and its comparative effects in wound healing and the treatment of inflammation. RSC Adv. 2019;9:20192.
  • 10. Kazemi M, Mohammadifar M, Aghadavoud E, Vakili Z, Aarabi MH, Talaei SA. Deep skin wound healing potential of lavender essential oil and licorice extract in a nanoemulsion form: Biochemical, histopathological and gene expression evidence. Journal of Tissue Viability. 2020;29:116-124.
  • 11. Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical drug delivery of lipophilic drugs, Int. J. Pharm. 2017; 526:353-365.
  • 12. Choudhury H, Gorain B, Pandey M, Chatterjee LA, Sengupta P, Das A et al.Recent Update on Nanoemulgel as Topical Drug Delivery System. J Pharm Sci. 2017;106(7):1736-1751.
  • 13. Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. Int J Pharm. 2017; 30;526(1-2):353-365.
  • 14. Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems- a review (Part 2). Trop. J. Pharmaceut. Res. 2013;12:265-273.
  • 15. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarriers systems. Pharmaceutics. 2018;10:57.
  • 16. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is below 5, which is beneficial for its resident flora. International Journal of Cosmetic Science. 2006; 28(5):359-370.
  • 17. El-Leithy ES, Makky AM, Khattab AM, Hussein DG. Nanoemulsion gel of nutraceutical co-enzyme Q10 as an alternative to conventional topical delivery system to enhance skin permeability and anti-wrinkle efficiency. International Journal of Pharmacy and Pharmaceutical Sciences. 2017; 9(10):207-217.
  • 18. Kandilli B, Ugur Kaplan AB, Cetin M, Taspinar N, Ertugrul MS, Aydin IC et al. Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method: in vitro and in vivo studies. Drug Development and Industrial Pharmacy. 2020;46(7):1063-1072.
Toplam 17 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Eczacılık ve İlaç Bilimleri
Bölüm Research Articles
Yazarlar

Ayse Sena Atmaca Bu kişi benim 0000-0002-4823-5277

Yasar Furkan Kılınboz Bu kişi benim 0000-0002-9646-4197

Afife Büşra Uğur Kaplan 0000-0003-2222-8789

Meltem Çetin 0000-0003-4009-2432

Yayımlanma Tarihi 6 Nisan 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 2 Sayı: 2

Kaynak Göster

EndNote Atmaca AS, Kılınboz YF, Uğur Kaplan AB, Çetin M (01 Nisan 2022) DEVELOPMENT AND IN VITRO CHARACTERIZATION OF NANOEMULSION AND NANOEMULSION BASED GEL CONTAINING ARTEMISIA DRACUNCULUS ETHANOL EXTRACT. International Journal of PharmATA 2 2 36–43.